Literature DB >> 24941664

Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channel.

Istvan Nagy, Dominic Friston, Jojo Sousa Valente, Jose Vicente Torres Perez, Anna P Andreou.   

Abstract

The capsaicin receptor, transient receptor potential vanilloid type 1 ion channel (TRPV1), has been identified as a polymodal transducer molecule on a sub-set of primary sensory neurons which responds to various stimuli including noxious heat (> -42 degrees C), protons and vanilloids such as capsaicin, the hot ingredient of chilli peppers. Subsequently, TRPV1 has been found indispensable for the development of burning pain and reflex hyperactivity associated with inflammation of peripheral tissues and viscera, respectively. Therefore, TRPV1 is regarded as a major target for the development of novel agents for the control of pain and visceral hyperreflexia in inflammatory conditions. Initial efforts to introduce agents acting on TRPV1 into clinics have been hampered by unexpected side-effects due to wider than expected expression in various tissues, as well as by the complex pharmacology, of TRPV1. However, it is believed that better understanding of the pharmacological properties of TRPV1 and specific targeting of tissues may eventually lead to the development of clinically useful agents. In order to assist better understanding of TRPV1 pharmacology, here we are giving a comprehensive account on the activation and inactivation mechanisms and the structure-function relationship of TRPV1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24941664     DOI: 10.1007/978-3-0348-0828-6_2

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  16 in total

1.  Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine.

Authors:  Vladimir Nerandzic; Petra Mrozkova; Pavel Adamek; Diana Spicarova; Istvan Nagy; Jiri Palecek
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

2.  Capsaicin Exerts Anti-convulsant and Neuroprotective Effects in Pentylenetetrazole-Induced Seizures.

Authors:  Omar M E Abdel-Salam; Amany A Sleem; Marawan Abd El Baset Mohamed Sayed; Eman R Youness; Nermeen Shaffie
Journal:  Neurochem Res       Date:  2020-02-08       Impact factor: 3.996

3.  The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4.

Authors:  Yan Li; Pavel Adamek; Haijun Zhang; Claudio Esteves Tatsui; Laurence D Rhines; Petra Mrozkova; Qin Li; Alyssa K Kosturakis; Ryan M Cassidy; Daniel S Harrison; Juan P Cata; Kenneth Sapire; Hongmei Zhang; Ross M Kennamer-Chapman; Abdul Basit Jawad; Andre Ghetti; Jiusheng Yan; Jiri Palecek; Patrick M Dougherty
Journal:  J Neurosci       Date:  2015-09-30       Impact factor: 6.167

Review 4.  The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

Authors:  Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

Review 5.  Mechanisms involved in the development of chemotherapy-induced neuropathy.

Authors:  Jessica A Boyette-Davis; Edgar T Walters; Patrick M Dougherty
Journal:  Pain Manag       Date:  2015-06-19

6.  Simultaneous hyperbaric oxygen therapy during systemic chemotherapy reverses chemotherapy-induced peripheral neuropathy by inhibiting TLR4 and TRPV1 activation in the central and peripheral nervous system.

Authors:  Ping-Ruey Chou; Ching-Yeh Lu; Jung-Yu Kan; Shih-Hung Wang; Jing-Jou Lo; Shu-Hung Huang; Sheng-Hua Wu
Journal:  Support Care Cancer       Date:  2021-05-18       Impact factor: 3.603

7.  Phosphorylated Histone 3 at Serine 10 Identifies Activated Spinal Neurons and Contributes to the Development of Tissue Injury-Associated Pain.

Authors:  Jose Vicente Torres-Pérez; Péter Sántha; Angelika Varga; Peter Szucs; Joao Sousa-Valente; Botond Gaal; Miklós Sivadó; Anna P Andreou; Sara Beattie; Bence Nagy; Klara Matesz; J Simon C Arthur; Gábor Jancsó; Istvan Nagy
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

Review 8.  Topical Treatments for Localized Neuropathic Pain.

Authors:  Roberto Casale; Z Symeonidou; M Bartolo
Journal:  Curr Pain Headache Rep       Date:  2017-03

Review 9.  TRPV1 Channel: A Potential Drug Target for Treating Epilepsy.

Authors:  Mustafa Nazıroğlu
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk.

Authors:  Jie Chen; Angelika Varga; Srikumaran Selvarajah; Agnes Jenes; Beatrix Dienes; Joao Sousa-Valente; Akos Kulik; Gabor Veress; Susan D Brain; David Baker; Laszlo Urban; Ken Mackie; Istvan Nagy
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.